相关实验视频

Updated: Jul 1, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

整合机器学习和结构分析来预测抗生物膜效应:生物膜相关感染的药物发现进展

Fatemeh Ebrahimi Tarki¹, Mahboobeh Zarrabi¹, Ahya Abdiali²

¹Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.

Iranian journal of pharmaceutical research : IJPR

|March 7, 2024

概括

这项研究开发了一种具有成本效益的计算方法来预测抗菌膜活性,有助于发现新的抗菌剂来对抗抗生素耐药细菌生物膜.

科学领域:

生物技术是生物技术.
计算生物学计算生物学
药物发现药物发现药物发现

背景情况:

抗生素耐药性是一个日益增长的全球健康威胁,由细菌生物膜加剧.
体显示出作为抗菌剂对抗耐药性感染的承诺.
开发新的抗菌膜剂对于应对这一危机至关重要.

研究的目的:

创建一个高效和经济的计算方法来预测抗菌膜活性.
为了促进具有强大的抗菌膜特性的新型的设计.
解决与传统药物发现相关的挑战和成本.

主要方法:

组装的正和负库. 组装的正和负库.
根据氨基酸序列,物理化学性质和分布计算特征向量.
采用监督学习算法来对抗菌膜进行分类.

主要成果:

在抗生素膜效应方面取得了高预测准确性 (99%).
证明了与现有方法可比的性能.
引入了一种新的方法,将特色空间与高抗菌膜活性相结合.

结论:

开发了一种可靠且具有成本效益的计算方法,用于预测抗菌膜效应.
启用了强大的抗生素膜序列的鉴定,用于实验验证.
为未来的研究和更新提供了可访问的源代码和数据 (hiABF).

关键词:

抗生素耐药性抗生素耐药性生物膜抑制生物膜抑制 ,监督机器学习

更多相关视频

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

相关概念视频

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...